Glenmark Life Sciences Ltd share price logo

Glenmark Life Sciences Ltd Share Price (GLS)

₹617.950.63%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q1 '23 Results
Technicals
News and Events

Overview of Glenmark Life Sciences Ltd

Key events for Glenmark Life Sciences Ltd

  • Nirma to Acquire Majority Stake in Glenmark Life Sciences - 22 Sep, 2023

    Nirma Ltd has agreed to acquire a 75% stake in Glenmark Life Sciences for ₹5,651.5 crore and will make a mandatory open offer for an additional 17.15% stake at ₹631/share. Meanwhile, Glenmark Pharma is set to sell its majority stake in the life sciences unit for $680 million.

  • Nirma Acquires Majority Stake in Glenmark Life Sciences - 21 Sep, 2023

    Glenmark Pharmaceuticals sells a 75% stake in Glenmark Life Sciences to Nirma Ltd for Rs 5,652 crore. The company will operate independently under new ownership.

  • Glenmark Life Sciences Included in Nifty 500 Index - 17 Aug, 2023

    Glenmark Life Sciences Ltd will be added to the Nifty 500 index, as per a recent announcement.

  • Glenmark Life Sciences Added to MSCI Global Small Cap Index - 11 Aug, 2023

    Glenmark Life Sciences Ltd has been added to the MSCI Global Smallcap Index, effective from August 31.

  • Nirma Eyes Acquisition of Glenmark Life Sciences - 28 Jul, 2023

    Nirma is planning to acquire companies in the healthcare sector and has shortlisted Glenmark Life Sciences for financial bids. The acquisition will help Nirma diversify its portfolio.

  • Nirma Group Shortlisted for Glenmark Life Sciences Bid - 27 Jul, 2023

    Glenmark Life Sciences witnesses remarkable growth, touching a 52-week high of Rs 673.2. Nirma Group is shortlisted to make a financial bid for the company, which may cost up to Rs 6,000 crore.

  • Glenmark Life Sciences Reports Strong Q1 Results and Successful IPO - 21 Jul, 2023

    Glenmark Life Sciences reports a 24% YoY increase in net profit for Q1 2023, while its IPO is subscribed 2.78 times on the second day of bidding, leading to a new 52-week high at Rs. 658.

  • Nirma and Sekhmet among final bidders for controlling stake in Glenmark Life Sciences - 15 Jul, 2023

    Nirma Ltd. and Sekhmet Pharmaventures, backed by PAG, are among the final bidders for a controlling stake in Glenmark Life Sciences valued at about $731 million. The move comes as Glenmark Pharma looks to raise cash and cut debt.

  • Shortlisted Bidders for Controlling Stake in Glenmark Life Sciences - 14 Jul, 2023

    Nirma Ltd. and PAG-backed Sekhmet Pharmaventures are among the shortlisted bidders for a controlling stake in Glenmark Life Sciences Ltd.

Analyst Rating for Glenmark Life Sciences Ltd stock

based on 5 analysts

BUY
80.00%
Buy
20.00%
Hold
0.00%
Sell

Based on 5 analysts offering long term price targets for Glenmark Life Sciences Ltd. An average target of ₹708.2

Source: S&P Global Market Intelligence

Glenmark Life Sciences Ltd share Performance

  • ₹617.05
    ₹626.9
    ₹617.95
    downward going graph

    0.15%

    Downside

    Day's Volatility:1.59%

    Upside

    1.45%

    downward going graph
  • ₹370
    ₹675
    ₹617.95
    downward going graph

    40.12%

    Downside

    52 Weeks Volatility:49.36%

    Upside

    9.23%

    downward going graph
1 Month Return0.61 %
3 Month Return9.26 %
1 Year Return63.47 %
Previous Close₹621.85
Open₹623.90
Volume1.82L
Market Cap₹7,619.35Cr

Glenmark Life Sciences Ltd Company Information

Glenmark Life Sciences Private Limited (formerly Zorg Laboratories Private Limited) was incorporated as a private limited company on 23 June 2011. It was acquired by Glenmark Pharmaceuticals Limited in July 2018, and was converted to a public company in August 2018. Operating as a wholly-owned subsidiary of Glenmark Pharmaceuticals, the company is engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs). The company has Research and Development (R&D) facilities in Mahape, Ankleshwar, and Dahej, while its manufacturing facilities are located in Ankleshwar, Dahej, Mohol, and Kurkumbh. On 13 August 2018, Glenmark Life Sciences allotted 4,500,090 equity shares of Rs. 10 each upon conversion of a loan given to the Director, and 15,000,000 shares to its parent company Glenmark Pharmaceuticals under preferential allotment. The company recently concluded its IPO, of a total of 21,022,222 equity shares, raising Rs. 15136 million. All of the outstanding purchase consideration was repaid from the proceeds of the IPO, and the company’s equity shares are now listed on both the BSE and NSE.

Share Price: ₹617.95 per share as on 29 Sep, 2023 04:01 PM
Market Capitalisation: ₹7,619.35Cr as of today
Listing date: 06 Aug, 2021
Chairperson Name: Glenn Saldanha
OrganisationGlenmark Life Sciences Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Fundamentals of Glenmark Life Sciences Ltd

Insights on Glenmark Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up
    img

    Mutual Funds have increased holdings from 0.00% to 0.52% in Jun 2023 quarter

  • imgPOSITIVE IMPACT

    Price Rise
    img

    In the last 6 months, GLS stock has moved up by 62.6%

  • imgPOSITIVE IMPACT

    Best in 1 Year
    img

    In the last 1 year, GLS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged
    img

    Promoters holdings remained unchanged at 82.85% of holdings in Jun 2023 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down
    img

    Foreign Institutions have decreased holdings from 3.29% to 3.27% in Jun 2023 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down
    img

    Retail Investor have decreased holdings from 13.86% to 13.30% in Jun 2023 quarter

Mutual Fund Holdings

Funds Holdings
Union Flexi Cap Fund Direct Growth OptionUnion Flexi Cap Fund Direct Growth Option0.98%
Union Small Cap Fund Direct GrowthUnion Small Cap Fund Direct Growth1.39%
Union Multicap Fund Direct GrowthUnion Multicap Fund Direct Growth1.44%
Union Tax saver (ELSS) Fund Direct Plan Growth OptionUnion Tax saver (ELSS) Fund Direct Plan Growth Option0.98%
Union Hybrid Equity Fund Direct GrowthUnion Hybrid Equity Fund Direct Growth0.7%

Glenmark Life Sciences Ltd Shareholding Pattern

InvestorsHoldings %Prev. 2 periods3M change
Promoter Holdings
82.85%
0.00
Foreign Institutions
3.27%
-0.36
Mutual Funds
0.52%
257800.00
Retail Investors
13.3%
-4.06
Others
0.06%
8371.43

Technicals of Glenmark Life Sciences Ltd share

News & Events of Glenmark Life Sciences Ltd

Frequently Asked Questions

Glenmark Life Sciences Ltd (GLS) share price today is ₹617.95

  • Today’s highest price of Glenmark Life Sciences Ltd is ₹626.9.
  • Today’s lowest price of Glenmark Life Sciences Ltd is ₹617.05.

Today’s traded volume of Glenmark Life Sciences Ltd(GLS) is 1.82L.

Today’s market capitalisation of Glenmark Life Sciences Ltd(GLS) is ₹7619.35Cr.

Glenmark Life Sciences Ltd(GLSPrice
52 Week High
₹675
52 Week Low
₹370

Glenmark Life Sciences Ltd(GLS) share price is ₹617.95. It is down -8.45% from its 52 Week High price of ₹675

Glenmark Life Sciences Ltd(GLS) share price is ₹617.95. It is up 67.01% from its 52 Week Low price of ₹370

Glenmark Life Sciences Ltd(GLSReturns
1 Day Returns
-3.9%
1 Month Returns
0.61%
3 Month Returns
9.26%
1 Year Returns
63.47%